Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) this morning announced its submittal of a Health Canada research application, as well as the appointment of Dr. Ed Ergenzinger to its executive team. The company’s research application, submitted under Health Canada’s Cannabis Tracking and Licensing System, is for the operation of an R&D laboratory to work with cannabinoids within Lexaria’s under construction Kelowna-based head office. According to the update, the laboratory will enhance Lexaria’s ability to formulate various products, which may contain cannabinoids or other controlled substances, for analytical purposes. In addition, the company appointed Dr. Ed Ergenzinger to the positions of chief legal officer and senior vice president of innovation. Ergenzinger is a U.S.-licensed patent attorney holding a doctorate in neuroscience (with concentrations in pharmacology and physiology) and an adjunct professor of law. He has over 15 years of experience providing patent services for clients ranging from small to some of the world’s largest pharmaceutical and biotechnology companies.
To view the full press release, visit http://nnw.fm/gE7Yo
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. licenses disruptive patented delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH™ delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com
More from NetworkNewsBreaks
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.networknewswire.com